CYBERDYNE (JP:7779) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
CYBERDYNE Inc. has received certification for its new Medical Vital Sensor ‘Cyvis M100’ in Japan, which will soon be covered by public health insurance. This innovative device promises to enhance cardiac monitoring with its ability to record heart activity for up to 10 days, aiding in the early detection and treatment of serious conditions like atrial fibrillation. The company plans to expand the Cyvis series to include additional health metrics, contributing to comprehensive healthcare solutions.
For further insights into JP:7779 stock, check out TipRanks’ Stock Analysis page.